NexLife Review

The ladder is the best thing here

Both drugs get their own page and both pages publish the same structure: a one-month rate with no commitment, then three prepaid terms, each with its own per-month figure and the saving stated beside it. Nothing is behind a quiz.

The pages also answer the question the ladder raises. The FAQ on each restates every rung in a sentence, so the grid and the prose agree — which sounds trivial until you notice how many sellers here publish a grid and then quote a different number in their own copy.

Both pages state that the price is the same at every dose and that there are no memberships or contracts, and the footer adds that medication costs are included in the selected programme unless stated otherwise. Forty-one of the ninety-five sellers here charge no membership.

Three starting figures for one drug

Here is the problem, and it is entirely internal to the site. The semaglutide plan page bottoms out at its twelve-month rate. The FAQ on that same page says the drug starts at a higher figure — the one-month rate — which is a defensible way to describe a floor.

The tirzepatide page then carries a sentence comparing the two drugs, and inside it quotes a semaglutide starting figure that is neither of those. It matches no rung on the ladder.

None of the three is hidden and none of them is enormous. But a reader who lands on the tirzepatide page and takes the comparison sentence at face value will arrive at checkout expecting a number the seller does not offer. Our record stores the four published rungs, and the qualifier on the lowest one records the contradiction rather than picking a winner.

The FDA letter, and what it does and does not say

The agency reviewed this site in March 2026 and wrote in June. The letter names the domain and a federal establishment identifier, and its finding is that the site's claims about its compounded semaglutide and tirzepatide products were false or misleading, which makes those products misbranded under two sections of the statute.

A warning letter is a disclosure, not a finding of guilt, and this roster does not treat one as a reason to exclude a seller or to score it down. Fourteen of the ninety-five sellers here carry one. The number, the date and a link to the agency's own text are on this row.

What we can say about today's pages is narrow and factual: the specific claim shape the agency cites most often across this field — that a compounded preparation contains the same active ingredient as a named brand drug — does not appear in the visible text of the semaglutide plan page as we read it. That is an observation about one page on one date, not a statement that anything has been resolved.

Credentials in place of names

Ask who fills the prescription and the answer is a list of qualifications: US-licensed 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and partners that may hold a certification, an accreditation, state board licensure or a federal registration. Every one of those is a category. Sixty-nine of the ninety-five sellers here name no compounding pharmacy at all.

Ask who prescribes and the answer is a care team of board-certified physicians, registered dietitians and care coordinators. No individual is named. Fifty-one of the ninety-five sellers here name nobody.

Ask where it operates and the answer is two words: licensed nationwide. That names no state and excludes none. We read both plan pages, the privacy-choices page and the homepage; there is no list. Fifty-eight of the ninety-five sellers here publish no service area at all.

What the site does publish about quality is specific and checkable in principle: it states that every batch is independently tested for potency, sterility, pH and endotoxin levels, and that it works only with pharmacies holding a named certification. That is a stronger claim than most of this field makes, and it would be stronger still with a pharmacy attached to it.

What the programme actually includes

The plans are itemised rather than gestured at: free expedited shipping, provider consultations, a personalised nutrition plan and a coaching call, each with a stated dollar value, adding to a total the site prints as included at no extra cost.

There is also a money-back warranty stated in the FAQ, conditioned on following the plan and a stated percentage of body weight over six months. Read the condition; a guarantee with a compliance requirement attached is a different product from one without.

And read the term. Every figure below the one-month rate requires paying for three, six or twelve months in a single charge. The site prints the saving in dollars beside each, which is the honest way to present it, but the money leaves at the start either way.